Brain Clearance Using Parenchymal and CSF Electrodes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Alzheimer's disease and cerebral amyloid angiopathy (CAA) are inadequate in effectively clearing amyloid beta and tau proteins from the brain, which contribute to the progression of these conditions.
Innovation Solution
An apparatus comprising parenchymal and cerebrospinal fluid (CSF) electrodes implanted in the brain, with control circuitry to drive these electrodes to clear substances like amyloid beta and tau proteins from the brain parenchyma into the CSF-filled space, and potentially from the CSF-filled space to the superior sagittal sinus, using electrical techniques such as electrophoresis or electroosmosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If electrical techniques are applied to clear amyloid beta and tau proteins from the brain, then the clearance efficiency of substances is improved, but the device complexity increases due to the need for implanted electrodes and control circuitry
Solution Approach 1:
The brain clearance system is segmented into distinct functional components: parenchymal electrodes for substance extraction, CSF electrodes for transport, and control circuitry for regulation. This segmentation allows each component to be optimized independently while working together to achieve effective amyloid and tau protein clearance from brain tissue.
Solution Approach 2:
Cerebrospinal fluid (CSF) acts as an intermediary medium in the clearance system. The CSF electrodes utilize the natural CSF flow pathways to transport cleared substances from the brain parenchyma to drainage sites, leveraging the body's existing physiological systems rather than creating entirely new transport mechanisms.
2Speed
If electrical currents are used to move substances from brain parenchyma into CSF-filled space, then the mobility of substances is improved, but the risk of harmful effects increases due to potential tissue damage from electrical stimulation
Solution Approach 1:
The electrical parameters (voltage, current density, pulse duration) are carefully controlled and optimized to achieve sufficient substance mobility while remaining below thresholds for harmful tissue effects. The system dynamically adjusts electrical parameters based on real-time feedback to maintain therapeutic effectiveness without causing damage.
Solution Approach 2:
The electrical clearance process operates continuously or in repeated cycles to maintain steady-state substance removal without requiring high-intensity intermittent pulses that could cause tissue damage. This continuous low-level stimulation achieves effective clearance while minimizing harmful effects.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described technique effectively moves amyloid beta and tau proteins from the brain parenchyma into the CSF-filled space, potentially slowing the progression of Alzheimer's disease and CAA by utilizing electrical currents to facilitate the clearance of these substances, as demonstrated by experimental results showing enhanced mobility and directionality of amyloid beta peptides.
Implementation Method 1
using electrical techniques such as electrophoresis or electroosmosis
Implementation Method 2
using electrical techniques such as electrophoresis or electroosmosis
Data Source
Figure 1A
Figure 1B
Figure 1C
AI summary
A system (20) is provided that includes a parenchymal electrode (30), configured to be implanted in brain parenchyma (50) of a subject identified as at risk of or suffering from a disease; and a cerebrospinal fluid (CSF) electrode (32), configured to be implanted in a CSF-filled space of a brain (52) of the subject, the CSF-filled space selected from the group consisting of: a ventricular system (54) and a subarachnoid space (144). Control circuitry (34) is configured to drive the parenchymal electrode (30) and the CSF electrode (32) to clear a substance from the brain parenchyma (50) into the CSF-filled space of the brain (52). Other embodiments are also described.